Cairo – Mubasher: Nile Co. for Pharmaceuticals and Chemical Industries (Nile Pharma) reported net profits of EGP 64.42 million in fiscal year (FY) 2020/2021, down by 31% year-on-year (YoY) from EGP 93.38 million, the modified financial results showed.
The revenues fell to EGP 755.51 million in the year ended 30 June, compared to EGP 812.54 million a year earlier, the company said in a bourse disclosure on Sunday.
During the first nine months of FY20/21, the company logged net profits of EGP 60.35 million, down from EGP 67.18 million in the prior-year period.
The revenues declined to EGP 621.1 million in the nine-month period ended 31 March, compared to EGP 671.99 million in the same period a year earlier.
